ICD-10 Code D59.2 | Drug-induced nonautoimmune hemolytic anemia Symptoms, Diagnosis, Billing

Drug-induced nonautoimmune hemolytic anemia is a condition characterized by the destruction of red blood cells due to the adverse effects of certain medications. This condition is clinically significant as it can lead to severe anemia and requires prompt diagnosis and management. The ICD-10 Code D59.2 facilitates accurate documentation, billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this condition.

What is ICD-10 Code D59.2 for Drug-induced nonautoimmune hemolytic anemia?

ICD-10 Code D59.2 represents Drug-induced nonautoimmune hemolytic anemia, a type of anemia caused by the destruction of red blood cells due to specific drugs. This code should be used when documenting cases where hemolysis is directly linked to medication use, allowing for appropriate clinical management and billing.

ICD-10 Code D59.2 – Clinical Definition and Explanation of Drug-induced nonautoimmune hemolytic anemia

Drug-induced nonautoimmune hemolytic anemia occurs when certain medications trigger the destruction of red blood cells without an autoimmune response. This condition can progress rapidly and may lead to significant morbidity if not addressed. Medical attention is crucial for diagnosis and management.

Key Clinical Features:

• History of recent medication use associated with hemolysis.
• Symptoms of anemia such as fatigue, pallor, and shortness of breath.
• Laboratory findings indicating hemolysis, including elevated bilirubin and decreased haptoglobin.
• Potential for acute onset of symptoms following drug exposure.

ICD-10 Code D59.2 for Drug-induced nonautoimmune hemolytic anemia – SOAP Notes & Clinical Use

ICD-10 Code D59.2 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to drug-induced nonautoimmune hemolytic anemia. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code D59.2 for Drug-induced nonautoimmune hemolytic anemia Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D59.2 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of drug-induced nonautoimmune hemolytic anemia. This ensures continuity of care and supports accurate billing and documentation standards.

Treatment Options for ICD-10 Code D59.2 – Drug-induced nonautoimmune hemolytic anemia

Management of drug-induced nonautoimmune hemolytic anemia often requires hospitalization for monitoring and treatment. Specific therapeutic approaches depend on the severity of the condition.

Antibiotic Therapy:

• Not applicable as this condition is not infectious.

Supportive Care:

• Discontinuation of the offending drug.
• Transfusion of red blood cells if severe anemia is present.
• Monitoring of hemoglobin levels and signs of hemolysis.

Infection Control:

• Standard precautions should be followed to prevent any secondary infections.

How to Document Symptoms of Drug-induced nonautoimmune hemolytic anemia (ICD-10 D59.2) in SOAP Notes

Subjective:

• Patient reports fatigue and weakness over the past week.
• History of recent medication changes, including antibiotics.
• Complaints of shortness of breath with exertion.
• Noted pallor on self-examination.

Objective:

• Vital signs: BP 110/70, HR 95, Temp 98.6°F.
• Laboratory results: Hemoglobin 8.5 g/dL, elevated indirect bilirubin.
• Physical exam: Pallor noted, no splenomegaly.
• Reticulocyte count elevated, indicating compensatory response.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Drug-induced nonautoimmune hemolytic anemia (ICD-10 Code D59.2)

Assessment:

• Diagnosis: Drug-induced nonautoimmune hemolytic anemia, moderate severity.
• ICD-10 Code: D59.2.
• Contributing factors: Recent antibiotic use.
• Monitor for potential complications of anemia.

Plan:

• Discontinue the suspected offending medication.
• Consider red blood cell transfusion if hemoglobin drops below 7 g/dL.
• Educate the patient on signs of worsening anemia.
• Schedule follow-up in one week to reassess hemoglobin levels.

Treatment & Plan Section for ICD-10 Code D59.2 – Drug-induced nonautoimmune hemolytic anemia

• Immediate cessation of the drug causing hemolysis.
• Transfusion of red blood cells if indicated by hemoglobin levels.
• Regular monitoring of complete blood counts and reticulocyte counts.
• Patient education on recognizing symptoms of anemia.

Using ICD-10 Code D59.2 for Drug-induced nonautoimmune hemolytic anemia in Billing & SOAP Note Compliance

• Ensure clear documentation of symptoms and medication history in Subjective (S) and Objective (O) sections.
• Use D59.2 when hemolysis is directly linked to drug exposure.
• Align treatment plans with clinical guidelines to support justified billing.
• Include relevant laboratory findings to substantiate the diagnosis.

Related ICD-10 Codes Often Used with Drug-induced nonautoimmune hemolytic anemia

• D59.0 – Acquired hemolytic anemia due to autoimmune disorders
• D59.1 – Acquired hemolytic anemia due to other specified causes
• D58.9 – Other specified disorders of red blood cells

ICD-10 Code D59.2 in Medical Billing and Insurance for Drug-induced nonautoimmune hemolytic anemia

ICD-10 Code D59.2 is essential for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant patient history and medication use to support the diagnosis.
• Ensure the code is used in conjunction with appropriate clinical findings.
• Include detailed notes on treatment plans and patient education.
• Utilize the code in both inpatient and outpatient settings for consistency.

Common CPT Pairings: